Samir N. Khleif, MD
Director

“The facilities are phenomenal, there is great teamwork and synergy between the research and clinical facilities, and there is just a tremendous amount of energy under the new leadership,” said Khleif, who was recruited from the National Institutes of Health, where he served as Chief of the National Cancer Institute’s Cancer Vaccine Section.

John K. Cowell, PhD, DSc, FRCPath

Acting Associate Director for Basic Sciences
Co-Leader, Molecular Oncology Program

Dr. John K. Cowell, a geneticist, edited the first and second editions of Molecular Biology of Cancer, published by Bios Publishing Corp., Oxford, UK. He also has contributed chapters to some 16 books on cancer biology. A full professor of pathology at MCG, his job at the Cancer Center will be to foster collaborative science among the investigators.

Anand Jillella, MBBS

Acting Associate Cancer Center Director for Clinical Affairs
Chief, Section of Hematology/Oncology

NCI-sponsored trials ask the best questions and are probably the most strictly conducted of the clinical trials, but a particular option may not work for everyone.

"That is why we rigorously test these concepts the way we do," says Dr. Anand Jillella, a medical oncologist.